Go Pro

Abivax (ABVX) News Today

Abivax logo
$141.45 -2.54 (-1.76%)
As of 03:54 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ABVX Latest News

Abivax logo displayed in a laboratory setting with a microscope, vials, and lab equipment on a counter.
Abivax: Wall Street Catches Up to the Data
Abivax stock surged over 40% after positive Phase 3 data on ulcerative colitis drug Obefazimod and a $920 million share offering that underwriters fully exercised, signaling strong institutional demand.
Abivax Announces Closing of $920 Million Public Offering
Promising Biotech Stocks To Follow Now - July 1st
Top Biotech Stocks To Keep An Eye On - June 30th
Abivax launches $600M underwritten public offering
Abivax shares jump as updated trial data eases safety concerns
Top Biotech Stocks To Keep An Eye On - June 24th
Abivax (ABVX) Jumps 16% on Bargain-Hunting
What's Going On With Abivax Stock On Thursday?
Get Abivax News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABVX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABVX Media Mentions By Week

ABVX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABVX
News Sentiment

0.48

0.55

Average
Medical
News Sentiment

ABVX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABVX Articles
This Week

31

6

ABVX Articles
Average Week

Get the Latest News and Ratings for ABVX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Abivax and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:ABVX) was last updated on 7/7/2026 by MarketBeat.com Staff.
From Our Partners